Birner-Grünberger Ruth, Scholze Hubert, Faber Kurt, Hermetter Albin
Department of Biochemistry, Technische Universität Graz, Petersgasse 12/2, A-8010 Graz, Austria.
Biotechnol Bioeng. 2004 Jan 20;85(2):147-54. doi: 10.1002/bit.10894.
We developed a specific method for determination and discrimination of lipo-/estero-lytic enzymes in crude lipase preparations. Here we study the composition of commercial porcine pancreatic lipase (PPL), since it is widely used for bioconversions of synthetic and natural substrates. Our method is based on incubation of enzyme samples with fluorescently labeled alkyl- or dialkylglyceryl-phosphonates in an appropriate solvent followed by protein separation by electrophoresis and fluorescence detection with a CCD camera. After incubation with short-chain alkylphosphonate solubilized by taurodeoxycholate, crude PPL preparations showed a very weak band at 50 kDa, which is indicative of low PPL concentrations in these samples. In addition, seven other fluorescent bands were detected. The band at the lowest molecular weight corresponded to alpha-chymotrypsin. Two intensive fluorescent bands were in the molecular weight range of chymotrypsinogen (26 kDa) and four weak bands were in the range 20-24 kDa. Long-chain dialkylglycerophosphonate labeled two protein bands in crude PPL: alpha-chymotrypsin and a very intensive band corresponding to the molecular weight of chymotrypsinogen. Detection of cholesterol esterase (98 kDa) in crude PPL preparations depended on addition of the protease inhibitor phenylmethylsulfonyl fluoride (PMSF) to the incubation mix, as demonstrated by spiking with cholesterol esterase. Thus, commercial crude PPL preparations contain a variety of estero-/lipo-lytic enzymes in addition to rather low amounts of active PPL, which should be considered when using crude PPL for bioconversions. Our method can also be used to show whether an isolated esterolytic activity corresponds to a single protein or isoenzymes. Here we confirm by 2D-electrophoretic separation of "pure" PPL that PPL exists as isoenzymes in different glycosylated forms.
我们开发了一种用于测定和区分粗脂肪酶制剂中脂解/酯解酶的特定方法。在此,我们研究市售猪胰脂肪酶(PPL)的组成,因为它广泛用于合成和天然底物的生物转化。我们的方法基于将酶样品与荧光标记的烷基或二烷基甘油膦酸酯在适当溶剂中孵育,然后通过电泳进行蛋白质分离并用CCD相机进行荧光检测。在用经牛磺脱氧胆酸盐溶解的短链烷基膦酸酯孵育后,粗PPL制剂在50 kDa处显示出非常弱的条带,这表明这些样品中PPL浓度较低。此外,还检测到其他七条荧光带。分子量最低的条带对应于α-胰凝乳蛋白酶。两条强荧光带在胰凝乳蛋白酶原的分子量范围内(26 kDa),四条弱带在20 - 24 kDa范围内。长链二烷基甘油膦酸酯标记了粗PPL中的两条蛋白带:α-胰凝乳蛋白酶和一条对应于胰凝乳蛋白酶原分子量的非常强的条带。如通过添加胆固醇酯酶所证实的,粗PPL制剂中胆固醇酯酶(98 kDa)的检测取决于向孵育混合物中添加蛋白酶抑制剂苯甲基磺酰氟(PMSF)。因此,市售粗PPL制剂除了含有相当少量的活性PPL外,还含有多种酯解/脂解酶,在将粗PPL用于生物转化时应予以考虑。我们的方法还可用于显示分离的酯解活性是对应于单一蛋白质还是同工酶。在此,我们通过对“纯”PPL进行二维电泳分离证实,PPL以不同糖基化形式的同工酶存在。